As drug regulatory submission accelerates toward digitalization, how can companies smoothly complete the CTD-to-eCTD conversion? How to properly build submission sequences and drive the end-to-end implementation of eCTD?
On October 22, we will gather in Shenzhen with industry experts and pharmaceutical regulatory affairs practitioners to share insights on the following topics:
- CTD-to-eCTD dossier conversion and sequence building
- End-to-end eCTD submission practices at pharmaceutical companies
- Live eCTD system demonstration
- Integrated application of medical translation and eCTD
- Interactive Q&A and experience exchange
- Date: October 22, 2026
- Venue: Room 2201, 22nd Floor, Building D3, Phase II, Nanshan Zhiyuan, Taoyuan Subdistrict, Nanshan District, Shenzhen
Co-organizers: Shenzhen Biomedical Industry Alliance, Oracle Translation (Shenzhen) Co., Ltd.
Seats are limited and registration closes once full; please sign up early.
Please scan the QR code on the poster to register. We look forward to meeting you on site!
